Kymera Investor Presentation Deck
Kymera Well-Positioned for Continued Success
• Kymera is executing on its mission to build a fully-integrated, global biotech
company as a recognized leader in TPD
• Our industry-leading R&D productivity has produced 4 clinical programs
and a deep and innovative pipeline of valuable, high-impact programs
We have demonstrated PK, PD and safety in Phase 1 trials that validate our
platform, molecule design and target selection capabilities and strategies
• We are well-capitalized with an experienced team that is highly focused
• We are only at the beginning of our journey, as Kymera's knowledge,
experience and drive positions us to maximize the untapped potential of
TPD in areas with large clinical and commercial opportunities
KYMERA ©2023 KYMERA THERAPEUTICS, INC.
PAGE 59View entire presentation